Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03991676 · ClinicalTrials.gov registry record · NA

A Study of a Values-Based Intervention to Promote Weight Loss

A NA study of Obesity and Weight Loss, sponsored by Drexel University.

Completed
Registry status
NA
Development phase
19
Enrollment target
1
Study location

NCT03991676: Completed NA study of Obesity and Weight Loss, sponsored by Drexel University.

NCT03991676 is a NA study of Obesity and Weight Loss that has completed, run by Drexel University. The registered enrollment target is 19 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03991676, a NA study of Obesity and Weight Loss, has completed, sponsored by Drexel University.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

More than 160 million American adults are overweight or obese. Existing weight loss interventions from self-help to gold standard behavioral treatments, while often effective, do not sufficiently maintain motivation to adhere to dietary goals in the face of powerful biological and environmental influences to consume highly palatable foods. Clarification and awareness of values, a staple of acceptance-based treatments drawn from Acceptance and Commitment Therapy, are thought to enhance autonomous motivation to engage in behaviors consistent with one's personal life values (e.g., health) in the presence of countervailing forces (e.g., hunger, deprivation). However, the independent efficacy of values clarification and awareness in facilitating weight control has never been tested. This pilot study seeks to investigate the feasibility and acceptability of a series of three weight loss workshops (based off the gold standard) infused with values clarification and awareness techniques to promote weight control. Participants will be asked to follow a reduced-calorie dietary prescription while holding their values in mind in moments of dietary decision-making over the course of one month. The primary aims of this study are to: 1) develop the series of values-infused workshops, using participant feedback to iterate and improve the treatment manual; and 2) evaluate treatment acceptability. Secondary aims are: 1) to evaluate whether clinically meaningful changes in measures of values clarification and values awareness occur; 2) to evaluate whether the intervention will lead participants to experience clinically meaningful changes in values-congruent weight control behaviors; 3) to evaluate whether the intervention will lead participants to experience clinically meaningful changes in weight; and 4) to evaluate theorized mechanisms of action in the intervention.

Primary Outcome

Participant acceptability and satisfaction with the intervention will be assessed using an idiosyncratic self-report Acceptability Questionnaire, developed for the present study. Questions include items assessing how satisfied participants were with the intervention, how helpful they found it, and how likely they would be to recommend it to others. Scores range from 1 to 5 for each item, where higher values represent greater satisfaction and acceptability.

Conditions Studied

Interventions

  • BEHAVIORAL Values-Based Behavioral Treatment

Study Locations (1)

Pennsylvania

  • Drexel University - Philadelphia

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2019-04-29
Est. Completion 2019-09-13
Phase NA
Drexel University

92 total trials

What the finished NCT03991676 record still lists

NCT03991676 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Values-Based Behavioral Treatment is the first listed.

NCT03991676 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03991676 about?

NCT03991676 is a clinical study titled "A Study of a Values-Based Intervention to Promote Weight Loss". More than 160 million American adults are overweight or obese. Existing weight loss interventions from self-help to gold standard behavioral treatments, while often effective, do not sufficiently maintain motivation to adhere to dietary goals in the face of powerful biological and environmental infl...

What is the current status of trial NCT03991676?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2019-04-29. Estimated completion is 2019-09-13.

What conditions does trial NCT03991676 study?

This clinical trial studies the following conditions: Obesity, Weight Loss.

What interventions are being tested in trial NCT03991676?

The interventions under investigation include: Values-Based Behavioral Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT03991676?

This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03991676 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03991676's enrollment target sits among peer trials

19 975th of 1053 higher than 73 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03991676, the US trial registry maintained by the National Library of Medicine. NCT03991676 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.